Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that its management team will be presenting at the Stifel 2018 Healthcare Conference on November 13, 2018 at the Lotte New York Palace Hotel in New York. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea.

Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that physicians presented updates from multiple clinical trials evaluating Inspire therapy for the treatment of OSA at the American Academy of Otolaryngology – Head Neck Surgery (AAO-HNSF) Annual Meeting and OTO Experience 2018, which took place from October 7 - 10, 2018, in Atlanta, GA. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the first implant of its new sensing lead (model number 4340) in Europe. The implant was successfully completed by Dr. Joachim Maurer, University Hospital, Mannheim, Germany, who has now overseen 80 Inspire therapy cases. Dr. Maurer is an Ear Nose and Throat (ENT) surgeon and Head of the Sleep Disorders Center.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 9) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Arrowhead Pharmaceuticals ...

Not a month into Inspire Medical Systems Inc (NYSE: INSP)’s life as a publicly traded company, the Street is coming to consensus. “We believe Inspire Medical Systems is well positioned to disrupt the obstructive sleep apnea market over the next several years,” Block said in a note.

As we continue to age and populations grow, demand for new and innovative healthcare solutions is only growing as well. Already preliminary data shows that MOR208 could be a better therapy than the so-called cell therapies when used in combination to cure cancer.

The medical technology company Inspire Medical Systems, Inc. (NYSE: INSP ) went public Thursday on the New York Stock Exchange. What Happened The company issued 6.75 million shares priced at $16 each. ...